Save your place

Sign in to WhoBought

Please try again later.

Verona Pharma plc (VRNA) institutional ownership

Market cap$8.9B SectorHealthcare
Funds holding · Q1 2026
1
reported VRNA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
0 buyers · 1 sellers

Verona Pharma plc (VRNA) price and institutional activity

Dates

Q1 2026

$0 bought by 0 investors
$0 sold by 1 investors
DekaBank Deutsche Girozentrale
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Verona Pharma plc (VRNA) institutional activity · 1

Investor Type Est. change Change Δ Own Date
DekaBank Deutsche Girozentrale · Exited
Change −20K Δ Own −100.0% Date Q1 2026
DekaBank Deutsche Girozentrale Exited· Q1 2026 −20K −100.0% Q1 2026
Data through Q1 2026 · filed Q1 2026
1 of 1

Famous investor activity in Verona Pharma plc (VRNA)

Verona Pharma plc (VRNA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Fisher Andrew · Officer 4 operations 0
Owned 0 Trade date Oct 7, 2025 Filed date Oct 8, 2025
Fisher Andrew Officer 4 operations 0 0 Oct 7, 2025 Oct 8, 2025
Fisher Andrew · Officer 3 operations -3.6M
Owned 0 Trade date Oct 7, 2025 Filed date Oct 8, 2025
Fisher Andrew Officer 3 operations -3.6M 0 Oct 7, 2025 Oct 8, 2025
Fisher Andrew · Officer Grant (A) 619K
Owned 619K Trade date Oct 7, 2025 Filed date Oct 8, 2025
Fisher Andrew Officer Grant (A) 619K 619K Oct 7, 2025 Oct 8, 2025
Zaccardelli David · Director, Officer 5 operations 0
Owned 0 Trade date Oct 7, 2025 Filed date Oct 8, 2025
Zaccardelli David Director, Officer 5 operations 0 0 Oct 7, 2025 Oct 8, 2025
Zaccardelli David · Director, Officer 2 operations -15.5M
Owned 0 Trade date Oct 7, 2025 Filed date Oct 8, 2025
Zaccardelli David Director, Officer 2 operations -15.5M 0 Oct 7, 2025 Oct 8, 2025
Zaccardelli David · Director, Officer Grant (A) 1.6M
Owned 1.6M Trade date Oct 7, 2025 Filed date Oct 8, 2025
Zaccardelli David Director, Officer Grant (A) 1.6M 1.6M Oct 7, 2025 Oct 8, 2025
Rickard Kathleen A. · Officer 5 operations 0
Owned 0 Trade date Oct 7, 2025 Filed date Oct 8, 2025
Rickard Kathleen A. Officer 5 operations 0 0 Oct 7, 2025 Oct 8, 2025
Rickard Kathleen A. · Officer 4 operations -4.2M
Owned 0 Trade date Oct 7, 2025 Filed date Oct 8, 2025
Rickard Kathleen A. Officer 4 operations -4.2M 0 Oct 7, 2025 Oct 8, 2025
Rickard Kathleen A. · Officer Grant (A) 619K
Owned 619K Trade date Oct 7, 2025 Filed date Oct 8, 2025
Rickard Kathleen A. Officer Grant (A) 619K 619K Oct 7, 2025 Oct 8, 2025
Hahn Mark W. · Officer 5 operations 0
Owned 0 Trade date Oct 7, 2025 Filed date Oct 8, 2025
Hahn Mark W. Officer 5 operations 0 0 Oct 7, 2025 Oct 8, 2025
Hahn Mark W. · Officer 2 operations -14.6M
Owned 0 Trade date Oct 7, 2025 Filed date Oct 8, 2025
Hahn Mark W. Officer 2 operations -14.6M 0 Oct 7, 2025 Oct 8, 2025
Hahn Mark W. · Officer Grant (A) 1.6M
Owned 1.6M Trade date Oct 7, 2025 Filed date Oct 8, 2025
Hahn Mark W. Officer Grant (A) 1.6M 1.6M Oct 7, 2025 Oct 8, 2025
Austwick Michael · Director 2 operations 0
Owned 0 Trade date Oct 7, 2025 Filed date Oct 8, 2025
Austwick Michael Director 2 operations 0 0 Oct 7, 2025 Oct 8, 2025
Austwick Michael · Director 3 operations -229K
Owned 0 Trade date Oct 7, 2025 Filed date Oct 8, 2025
Austwick Michael Director 3 operations -229K 0 Oct 7, 2025 Oct 8, 2025
Ullman Anders · Director 2 operations 0
Owned 0 Trade date Oct 7, 2025 Filed date Oct 8, 2025
Ullman Anders Director 2 operations 0 0 Oct 7, 2025 Oct 8, 2025
15 of 62
15 of 62 Sign in to continue to older insider transactions.

Verona Pharma plc (VRNA) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ra Capital Management, L.P. 8.5M
% of shares outstanding 10.0% Filing date Nov 14, 2024
Ra Capital Management, L.P. 8.5M 10.0% Nov 14, 2024
Growth Equity Opportunities Fund Iv, LLC 44.7M
% of shares outstanding 6.9% Filing date Aug 28, 2024
Growth Equity Opportunities Fund Iv, LLC 44.7M 6.9% Aug 28, 2024
BlackRock Portfolio Management LLC 27.6M
% of shares outstanding 6.0% Filing date Oct 17, 2025
BlackRock Portfolio Management LLC 27.6M 6.0% Oct 17, 2025
Maverick Capital Ltd 33.7M
% of shares outstanding 5.2% Filing date Nov 14, 2024
Maverick Capital Ltd 33.7M 5.2% Nov 14, 2024
Orbimed Advisors LLC 3.8M
% of shares outstanding 4.8% Filing date May 16, 2023
Orbimed Advisors LLC 3.8M 4.8% May 16, 2023
Wellington Management Group LLP 30.3M
% of shares outstanding 4.7% Filing date Feb 8, 2024
Wellington Management Group LLP 30.3M 4.7% Feb 8, 2024
Abingworth LLP 21.3M
% of shares outstanding 4.4% Filing date Aug 11, 2022
Abingworth LLP 21.3M 4.4% Aug 11, 2022
Deep Track Capital, LP
% of shares outstanding 3.9% Filing date Nov 14, 2024
Deep Track Capital, LP 3.9% Nov 14, 2024
8 of 13

Verona Pharma plc (VRNA) ownership FAQ

Who owns VRNA?

1 reporting institutions disclosed VRNA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.